Pharma giants bag Lynparza EMA approval for metastatic breast cancer
Lynparza EMA approval : Pharma giants AstraZeneca and MSD have secured an expansion of the European Medical Agency’s (EMA) approval
Continue reading
Tag: AstraZeneca
FDA approves AstraZeneca’s Lumoxiti for hairy cell leukaemia treatment
Lumoxiti FDA approval : AstraZeneca has bagged the US Food and Drug Administration (FDA) approval for its CD22-directed cytotoxin Lumoxiti
Continue reading
AstraZeneca, Amgen asthma drug tezepelumab secures FDA breakthrough designation
UK biopharma company AstraZeneca and Amgen have secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for
Continue reading
CHMP recommends AstraZeneca lung cancer drug Imfinzi EMA approval
Update on Imfinzi EMA approval : The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency
Continue readingAcalabrutinib wins US FDA approval for mantle cell lymphoma treatment
Acalabrutinib FDA approval : AstraZeneca has secured an early approval for its blood cancer drug Calquence (acalabrutinib) for the treatment
Continue readingAstraZeneca lung cancer drug Tagrisso gets FDA breakthrough therapy designation
Pharma news updates : Tagrisso (osimertinib), the AstraZeneca lung cancer drug has bagged the breakthrough therapy designation (BTD) from the
Continue readingAstrazeneca ovarian cancer drug Lynparza shown to improve survival chances
Pharma giant AstraZeneca has reported that its ovarian cancer drug Lynparza (olaparib) as a maintenance therapy has considerably improved the
Continue readingAstraZeneca, Sanofi form R&D alliance for infant respiratory drug
AstraZeneca’s MedImmune and Sanofi Pasteur have formed a research and development alliance for a new infant respiratory drug, MEDI8897 which
Continue reading
